A randomised in-practice evaluation of the influence of patient's understanding of her disease and therapy on persistence and compliance to adjuvant therapy for post-menopausal hormone-sensitive early breast cancer.

Trial Profile

A randomised in-practice evaluation of the influence of patient's understanding of her disease and therapy on persistence and compliance to adjuvant therapy for post-menopausal hormone-sensitive early breast cancer.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 17 Apr 2013

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms PACT
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Jun 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003872).
    • 22 Jun 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Twelve and 24-month follow-up results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top